Carbon nanotubes for drug delivery applications

Yitzhak Rosen, Pablo Gurman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

During the last years, pharmaceutical companies have been facing the challenge of developing new molecules to replace the existing ones in order to sustain their core business. This became a very expensive, time-consuming and frustrating task. It is now being realized that an alternative to drug development is to reuse the existing drugs by changing their pharmacokinetic or pharmacodynamic properties thanks to their incorporation to drug carriers. The so-called drug delivery systems hold promise to optimize drug absorption, distribution, metabolism and excretion (pharmacokinetics), and ultimately to improve the clinical effi cacy of pharmacotherapies. In the last 20 years with the advent of micro- and nano-technologies, a variety of micro- and nano-devices including nanostructures have been developed for their application as drug delivery systems. Among them, carbon nanotubes, carbon fi bers with a few nanometers in diameter and several microns length, have called the attention of the scientifi c community due to their large surface area, high aspect ratio and their extraordinary mechanical and electrical properties. Carbon nanotubes are produced by different methods, including chemical vapor deposition, laser ablation and arc discharge. Carbon nanotubes have been investigated for applications ranging from cancer therapy to gene therapy and small interfering ribonucleic acid delivery. However, a serious concern is the potential toxicity of carbon nanotubes as has been shown in vitro and in vivo. Ultimately, a balance between benefi ts and risks will dictate whether carbon nanotube-based drug delivery systems will reach the market in the years to come.

Original languageEnglish (US)
Title of host publicationNanotechnology and Drug Delivery
Subtitle of host publicationVolume 1: Nanoplatforms in Drug Delivery
PublisherCRC Press
Pages233-248
Number of pages16
ISBN (Electronic)9781466599482
ISBN (Print)9781466599475
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Carbon Nanotubes
Drug delivery
Carbon nanotubes
Drug Delivery Systems
Pharmacokinetics
Pharmaceutical Preparations
Pharmacodynamics
Technology
Drug therapy
Gene therapy
Equipment and Supplies
Drug Carriers
Nanostructures
Laser Therapy
Laser ablation
RNA
Nanotechnology
Metabolism
Genetic Therapy
Drug products

ASJC Scopus subject areas

  • Medicine(all)
  • Engineering(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Rosen, Y., & Gurman, P. (2014). Carbon nanotubes for drug delivery applications. In Nanotechnology and Drug Delivery: Volume 1: Nanoplatforms in Drug Delivery (pp. 233-248). CRC Press. https://doi.org/10.1201/b17271

Carbon nanotubes for drug delivery applications. / Rosen, Yitzhak; Gurman, Pablo.

Nanotechnology and Drug Delivery: Volume 1: Nanoplatforms in Drug Delivery. CRC Press, 2014. p. 233-248.

Research output: Chapter in Book/Report/Conference proceedingChapter

Rosen, Y & Gurman, P 2014, Carbon nanotubes for drug delivery applications. in Nanotechnology and Drug Delivery: Volume 1: Nanoplatforms in Drug Delivery. CRC Press, pp. 233-248. https://doi.org/10.1201/b17271
Rosen Y, Gurman P. Carbon nanotubes for drug delivery applications. In Nanotechnology and Drug Delivery: Volume 1: Nanoplatforms in Drug Delivery. CRC Press. 2014. p. 233-248 https://doi.org/10.1201/b17271
Rosen, Yitzhak ; Gurman, Pablo. / Carbon nanotubes for drug delivery applications. Nanotechnology and Drug Delivery: Volume 1: Nanoplatforms in Drug Delivery. CRC Press, 2014. pp. 233-248
@inbook{add394f9ca07461d9097cd748d666b90,
title = "Carbon nanotubes for drug delivery applications",
abstract = "During the last years, pharmaceutical companies have been facing the challenge of developing new molecules to replace the existing ones in order to sustain their core business. This became a very expensive, time-consuming and frustrating task. It is now being realized that an alternative to drug development is to reuse the existing drugs by changing their pharmacokinetic or pharmacodynamic properties thanks to their incorporation to drug carriers. The so-called drug delivery systems hold promise to optimize drug absorption, distribution, metabolism and excretion (pharmacokinetics), and ultimately to improve the clinical effi cacy of pharmacotherapies. In the last 20 years with the advent of micro- and nano-technologies, a variety of micro- and nano-devices including nanostructures have been developed for their application as drug delivery systems. Among them, carbon nanotubes, carbon fi bers with a few nanometers in diameter and several microns length, have called the attention of the scientifi c community due to their large surface area, high aspect ratio and their extraordinary mechanical and electrical properties. Carbon nanotubes are produced by different methods, including chemical vapor deposition, laser ablation and arc discharge. Carbon nanotubes have been investigated for applications ranging from cancer therapy to gene therapy and small interfering ribonucleic acid delivery. However, a serious concern is the potential toxicity of carbon nanotubes as has been shown in vitro and in vivo. Ultimately, a balance between benefi ts and risks will dictate whether carbon nanotube-based drug delivery systems will reach the market in the years to come.",
author = "Yitzhak Rosen and Pablo Gurman",
year = "2014",
month = "1",
day = "1",
doi = "10.1201/b17271",
language = "English (US)",
isbn = "9781466599475",
pages = "233--248",
booktitle = "Nanotechnology and Drug Delivery",
publisher = "CRC Press",
address = "United States",

}

TY - CHAP

T1 - Carbon nanotubes for drug delivery applications

AU - Rosen, Yitzhak

AU - Gurman, Pablo

PY - 2014/1/1

Y1 - 2014/1/1

N2 - During the last years, pharmaceutical companies have been facing the challenge of developing new molecules to replace the existing ones in order to sustain their core business. This became a very expensive, time-consuming and frustrating task. It is now being realized that an alternative to drug development is to reuse the existing drugs by changing their pharmacokinetic or pharmacodynamic properties thanks to their incorporation to drug carriers. The so-called drug delivery systems hold promise to optimize drug absorption, distribution, metabolism and excretion (pharmacokinetics), and ultimately to improve the clinical effi cacy of pharmacotherapies. In the last 20 years with the advent of micro- and nano-technologies, a variety of micro- and nano-devices including nanostructures have been developed for their application as drug delivery systems. Among them, carbon nanotubes, carbon fi bers with a few nanometers in diameter and several microns length, have called the attention of the scientifi c community due to their large surface area, high aspect ratio and their extraordinary mechanical and electrical properties. Carbon nanotubes are produced by different methods, including chemical vapor deposition, laser ablation and arc discharge. Carbon nanotubes have been investigated for applications ranging from cancer therapy to gene therapy and small interfering ribonucleic acid delivery. However, a serious concern is the potential toxicity of carbon nanotubes as has been shown in vitro and in vivo. Ultimately, a balance between benefi ts and risks will dictate whether carbon nanotube-based drug delivery systems will reach the market in the years to come.

AB - During the last years, pharmaceutical companies have been facing the challenge of developing new molecules to replace the existing ones in order to sustain their core business. This became a very expensive, time-consuming and frustrating task. It is now being realized that an alternative to drug development is to reuse the existing drugs by changing their pharmacokinetic or pharmacodynamic properties thanks to their incorporation to drug carriers. The so-called drug delivery systems hold promise to optimize drug absorption, distribution, metabolism and excretion (pharmacokinetics), and ultimately to improve the clinical effi cacy of pharmacotherapies. In the last 20 years with the advent of micro- and nano-technologies, a variety of micro- and nano-devices including nanostructures have been developed for their application as drug delivery systems. Among them, carbon nanotubes, carbon fi bers with a few nanometers in diameter and several microns length, have called the attention of the scientifi c community due to their large surface area, high aspect ratio and their extraordinary mechanical and electrical properties. Carbon nanotubes are produced by different methods, including chemical vapor deposition, laser ablation and arc discharge. Carbon nanotubes have been investigated for applications ranging from cancer therapy to gene therapy and small interfering ribonucleic acid delivery. However, a serious concern is the potential toxicity of carbon nanotubes as has been shown in vitro and in vivo. Ultimately, a balance between benefi ts and risks will dictate whether carbon nanotube-based drug delivery systems will reach the market in the years to come.

UR - http://www.scopus.com/inward/record.url?scp=85054442128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054442128&partnerID=8YFLogxK

U2 - 10.1201/b17271

DO - 10.1201/b17271

M3 - Chapter

AN - SCOPUS:85054442128

SN - 9781466599475

SP - 233

EP - 248

BT - Nanotechnology and Drug Delivery

PB - CRC Press

ER -